Peter A. Fasching, MD, Prof.
Department of Gynecology and Obstetrics, Erlangen University Hospital
2
0
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Tanja Fehm, MD, Prof.
Department of Gynecology/Obstetrics |University Hospital Düsseldorf, Germany
Shared therapeutic areas:
Worked with same sponsors:
Andreas Schneeweiss, MD, Prof.
National Center for Tumor Diseases (NCT) | Heidelberg University Hospital and German Cancer Research Center
Shared therapeutic areas:
Worked with same sponsors:
Puma
Biotechnology
Shared therapeutic areas:
Norman Wolmark, MD
NSABP Foundation Inc
Shared therapeutic areas:
Worked with same sponsors:
XiaoFeng Shen, MD
Nanjing Medical University
Shared therapeutic areas:
Alice P Chen, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Project Leader
Ono Pharmaceutical Co., Ltd.
Shared therapeutic areas:
min yan
Henan Cancer Hospital
Shared therapeutic areas:
Amal Fawzy, Ph.d
Faculty of Physical Therapy, Ahram Canadian University
Shared therapeutic areas:
Lizhi Niu, PhD
Fuda Cancer Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients
Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency (COMPRENDO
All 2 trials loaded